Editas Medicine, Inc. EDIT
Set alert
2.63 USD +0.06 +2.32%
As of Nov 3, 11:32 AM ET
2.58 Day range 2.71
1.66 52-week range 3.94
- YTD
- +28.28%
- 1 year
- -14.06%
- Open
- 2.61
- Prev close
- 2.57
- Mkt cap
- 403.72M
- Vol
- 697.77K
- Avg vol
- 2.69M
- EPS
- -0.68
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.58
- High
- 2.71
- Forward P/E
- -0.53
- Beta
- 2.01
- Short ratio
- 6.70
- Inst. own
- 70.94%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.60
- 200-d avg
- 4.55
- 1y target
- 3.67
5Y chart
Events in this range
- Aug 2, 2023Earnings: -0.56; estimate -0.76; surprise 26.32%
- Nov 3, 2023Earnings: -0.55; estimate -0.64; surprise 14.06%
- Feb 28, 2024Earnings: -0.23; estimate -0.52; surprise 55.77%
- May 8, 2024Earnings: -0.76; estimate -0.63; surprise -20.63%
- Aug 7, 2024Earnings: -0.82; estimate -0.69; surprise -18.84%
- Nov 4, 2024Earnings: -0.75; estimate -0.76; surprise 1.32%
- Dec 13, 2024Rating: Baird · Outperform → Outperform
- Dec 13, 2024Downgrade: Chardan Capital · Buy → Neutral
- Dec 13, 2024Rating: Barclays · Equal-Weight → Equal-Weight
- Dec 13, 2024Rating: RBC Capital · Sector Perform → Sector Perform
- Dec 16, 2024Downgrade: JP Morgan · Neutral → Underweight
- Dec 16, 2024Rating: Evercore ISI Group · Outperform → Outperform
Signals (92)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| SMA: Bearish | Sep 7, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 7, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 31, 2026 | 2 months ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 10, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 20, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 29, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 15, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 9, 2026 | 7 months ago |
Newest 20 of 92.
Analyst view
Consensus: hold
Hold
Price target (mean) 3.67 +39.4% upside
Now 2.63
- Target (low)
- 1.00
- Target (mean)
- 3.67
- Target (high)
- 8.00
Ratings (0m) 18 4 buy · 12 hold · 2 sell
- Strong buy0
- Buy4
- Hold12
- Sell0
- Strong sell2
Recommendation trend
- This month 18
- 1 month ago 19
- 2 months ago 19
- 3 months ago 19
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.3561 | -0.87 – 0.10 | -0.23 | -54.8% | 36.02M | -40.0% | 15 |
| Next quarter | -0.52731 | -0.83 – -0.33 | -0.76 | +30.6% | 808.71K | -28.7% | 8 |
| Current year | -2.68 | -3.20 – -2.20 | -2.02 | -32.5% | 43.36M | -44.5% | 15 |
| Next year | -1.50 | -3.31 – -0.17 | -2.68 | +44.1% | 20.87M | -51.9% | 15 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 16, 2024 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Dec 16, 2024 | JP Morgan | Downgrade | Neutral | Underweight |
| Dec 13, 2024 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Dec 13, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Dec 13, 2024 | Chardan Capital | Downgrade | Buy | Neutral |
| Dec 13, 2024 | Baird | Maintained | Outperform | Outperform |
| Dec 13, 2024 | Stifel | Downgrade | Buy | Hold |
| Dec 11, 2024 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Nov 5, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Nov 5, 2024 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Nov 5, 2024 | Stifel | Maintained | Buy | Buy |
| Nov 5, 2024 | Truist Securities | Maintained | Buy | Buy |
| Nov 5, 2024 | Wells Fargo | Maintained | Overweight | Overweight |
| Nov 5, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 23, 2024 | Evercore ISI Group | Maintained | In-Line | In-Line |
| Oct 23, 2024 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 22, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Sep 19, 2024 | RBC Capital | Reiterated | Sector Perform | Sector Perform |
| Sep 17, 2024 | Jones Trading | Initiated | — | Buy |
| Aug 8, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Aug 8, 2024 | Truist Securities | Maintained | Buy | Buy |
| Aug 8, 2024 | B of A Securities | Upgrade | Neutral | Buy |
| Jun 18, 2024 | Oppenheimer | Maintained | Perform | Perform |
| May 30, 2024 | Evercore ISI Group | Maintained | In-Line | In-Line |
| May 9, 2024 | Citigroup | Maintained | Buy | Buy |
| May 9, 2024 | Morgan Stanley | Upgrade | Underweight | Equal-Weight |
| May 9, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Feb 29, 2024 | Citigroup | Maintained | Buy | Buy |
| Feb 29, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Feb 27, 2024 | JP Morgan | Maintained | Neutral | Neutral |